Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 304

1.

Liver Transplantation for Hepatocellular Carcinoma: A Single Center Resume Overlooking Four Decades of Experience.

Emmanouilidis N, Peters R, Ringe BP, Güner Z, Ramackers W, Bektas H, Lehner F, Manns M, Klempnauer J, Schrem H.

J Transplant. 2016;2016:7895956. doi: 10.1155/2016/7895956. Epub 2016 Jan 10.

2.

Value of oral effervescent powder administration for multidetector CT evaluation of esophageal cancer.

Ringe KI, Meyer S, Ringe BP, Winkler M, Wacker F, Raatschen HJ.

Eur J Radiol. 2015 Feb;84(2):215-20. doi: 10.1016/j.ejrad.2014.11.008. Epub 2014 Nov 18.

PMID:
25497235
3.

Evaluation of living liver donors using contrast enhanced multidetector CT - The radiologists impact on donor selection.

Ringe KI, Ringe BP, von Falck C, Shin HO, Becker T, Pfister ED, Wacker F, Ringe B.

BMC Med Imaging. 2012 Jul 24;12:21. doi: 10.1186/1471-2342-12-21.

4.

Characterization and staging of central bile duct stenosis--evaluation of the hepatocyte specific contrast agent gadoxetate disodium.

Ringe KI, Ringe BP, Bektas H, Opherk JP, Reichelt A, Lotz J, Wacker F, Meyer BC.

Eur J Radiol. 2012 Nov;81(11):3028-34. doi: 10.1016/j.ejrad.2012.03.030. Epub 2012 Jun 27.

PMID:
22742848
5.

Extended right liver grafts obtained by an ex situ split can be used safely for primary and secondary transplantation with acceptable biliary morbidity.

Takebe A, Schrem H, Ringe B, Lehner F, Strassburg C, Klempnauer J, Becker T.

Liver Transpl. 2009 Jul;15(7):730-7. doi: 10.1002/lt.21745.

6.

From Abernethy to APOLT.

Ringe KI, Galanski M, Ringe B.

Liver Transpl. 2008 Jul;14(7):1067-8. doi: 10.1002/lt.21457. No abstract available.

7.

Rescue of a living donor with liver transplantation.

Ringe B, Xiao G, Sass DA, Karam J, Shang S, Maroney TP, Trebelev AE, Levison S, Fuchs AC, Petrucci R, Ko A, Gonzalez M, Reynolds JC, Meyers WC.

Am J Transplant. 2008 Jul;8(7):1557-61. doi: 10.1111/j.1600-6143.2008.02261.x.

8.

Role of liposomal amphotericin B (AmBisome) in the prophylaxis of mycoses after liver transplantation.

Braun F, Ringe B.

Rev Iberoam Micol. 1999 Jun;16(2):69-71. No abstract available.

9.

The dilemma of living liver donor death: to report or not to report?

Ringe B, Strong RW.

Transplantation. 2008 Mar 27;85(6):790-3. doi: 10.1097/TP.0b013e318167345e. Review.

PMID:
18360257
10.

[Congenital absence of the portal vein (CAPV). Two cases of Abernethy malformation type 1 and review of the literature].

Ringe K, Schirg E, Melter M, Flemming P, Ringe B, Becker T, Galanski M.

Radiologe. 2008 May;48(5):493-502. Review. German.

PMID:
17879079
11.

Death of a living liver donor from illicit drugs.

Ringe B, Petrucci RJ, Soriano HE, Reynolds JC, Meyers WC.

Liver Transpl. 2007 Aug;13(8):1193-4.

12.

Hepatic artery-portal vein fistula formation after percutaneous liver biopsy in a living liver donor.

Gabriel S, Maroney TP, Ringe BH.

Transplant Proc. 2007 Jun;39(5):1707-9.

PMID:
17580227
13.

Pancreas transplantation with histidine-tryptophan-ketoglutarate (HTK) solution and University of Wisconsin (UW) solution: is there a difference?

Becker T, Ringe B, Nyibata M, Meyer zu Vilsendorf A, Schrem H, Lück R, Neipp M, Klempnauer J, Bektas H.

JOP. 2007 May 9;8(3):304-11.

15.

Successful liver transplantation in two cases of metastatic gastrointestinal stromal tumors.

Cameron S, Ramadori G, Füzesi L, Sattler B, Gunawan B, Müller D, Ringe B, Lorf T.

Transplantation. 2005 Jul 27;80(2):283-4. No abstract available.

PMID:
16041278
16.

What is the best immunosuppression in living donor liver transplantation?

Ringe B, Moritz M, Zeldin G, Soriano H.

Transplant Proc. 2005 Jun;37(5):2169-71.

PMID:
15964369
17.

Safety and efficacy of living donor liver preservation with HTK solution.

Ringe B, Braun F, Moritz M, Zeldin G, Soriano H, Meyers W.

Transplant Proc. 2005 Jan-Feb;37(1):316-9.

PMID:
15808629
18.

Effects of cyclosporine on human dendritic cell subsets.

Ciesek S, Ringe BP, Strassburg CP, Klempnauer J, Manns MP, Wedemeyer H, Becker T.

Transplant Proc. 2005 Jan-Feb;37(1):20-4.

PMID:
15808533
19.

Initial steroid-free immunosuppression after liver transplantation in recipients with hepatitis C virus related cirrhosis.

Wietzke-Braun P, Braun F, Sattler B, Ramadori G, Ringe B.

World J Gastroenterol. 2004 Aug 1;10(15):2213-7.

20.

Histidine-tryptophan-ketoglutarate solution for organ preservation in human liver transplantation-a prospective multi-centre observation study.

Pokorny H, Rasoul-Rockenschaub S, Langer F, Windhager T, Rosenstingl A, Lange R, Königsrainer A, Ringe B, Mühlbacher F, Steininger R.

Transpl Int. 2004 Jun;17(5):256-60. Epub 2004 May 25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk